Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

PI3K inhibitor umbralisib shows clinical activity in patients with indolent non-Hodgkin's lymphoma

March 10, 2021

Artios Pharma describes new POLQ inhibitors

March 10, 2021

Wigen Biomedicine Technology divulges KRAS mutant inhibitors

March 10, 2021

Pirtobrutinib demonstrates safety and efficacy in multiple B-cell malignancies

March 10, 2021

Dovitinib demonstrates promising antitumor activity in preclinical model of osteosarcoma

March 10, 2021

New model for invasive lobular carcinoma points to LOXL1 as a therapeutic target

March 9, 2021

IL-17 receptor's "B team" may be pancreatic cancer target

March 9, 2021

Bayer and DKFZ patent AhR antagonists

March 9, 2021

Chinese investigators identify new TGFBR1 inhibitors

March 9, 2021

Artios Pharma divulges POLQ inhibitors

March 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...